Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pediatric Multiple Sclerosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT02890641
What this trial is testing

Genetic and Electrophysiologic Study in Focal Drug-resistant Epilepsies

Who this might be right for
Drug-resistant Focal Epilepsies in Pediatric Population
Fondation Ophtalmologique Adolphe de Rothschild 450
Large-scale testing (Phase 3)Not Yet RecruitingNCT07483632
What this trial is testing

Learn About the Safety of Diroximel Fumarate (DRF) and Dimethyl Fumarate (DMF) and Their Effects on Relapses in Pediatric Participants With Relapsing Forms of Multiple Sclerosis (RMS)

Who this might be right for
Relapsing Forms of Multiple Sclerosis
Biogen 185
Not applicableStudy completedNCT02137109
What this trial is testing

Safety and Efficacy in Pediatric MS Patients Prescribed Tysabri

Who this might be right for
Multiple Sclerosis
Biogen 400
Not applicableLooking for participantsNCT07360977
What this trial is testing

Myrosinase Bioactivated Gglucoraphanin for the Treatment of Neurodegenerative Diseases (GRA-MYR-ND)

Who this might be right for
PARKINSON DISEASE (Disorder)Multiple Sclerosis (MS) - Relapsing-remittingPediatric Patients Affected by Neuromuscolar and Degenerative Diseases
IRCCS Centro Neurolesi Bonino Pulejo 300
Not applicableStudy completedNCT02234713
What this trial is testing

Adherence in Pediatric Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
The Hospital for Sick Children 71
Not applicableStudy completedNCT03190902
What this trial is testing

Cognitive Impairment in Pediatric Onset Multiple Sclerosis

Who this might be right for
Pediatric Onset Multiple SclerosisADHD Predominantly Inattentive Type
Pietro Iaffaldano 36
Not applicableLooking for participantsNCT06764602
What this trial is testing

Observational, Retrospective, Multicenter, Nonprofit Study on the Prevalence of Renal Involvement in Pediatric Patients With Tuberous Sclerosis

Who this might be right for
Tuberous Sclerosis Complex (TSC)
IRCCS Azienda Ospedaliero-Universitaria di Bologna 80
Not applicableStudy completedNCT03067025
What this trial is testing

Sleep, Physical Activity and Multiple Sclerosis Symptoms in Pediatric Multiple Sclerosis

Who this might be right for
Pediatric Multiple Sclerosis
The Hospital for Sick Children 50
Not applicableEnded earlyNCT03933020
What this trial is testing

Impact of Physical Activity on Cognitive Outcomes in Youth With Pediatric-Onset Multiple Sclerosis (POMS)

Who this might be right for
Pediatric Onset Multiple Sclerosis (POMS)
The University of Texas Health Science Center, Houston 2
Not applicableStudy completedNCT03942952
What this trial is testing

PEDIATRIC SONICS: Pediatric Study of Neuropsychology and Imaging in CNS Demyelinating Syndromes.

Who this might be right for
Multiple Sclerosis, Relapsing-RemittingNeuromyelitis OpticaAcute Disseminated Encephalomyelitis+1 more
University of Texas Southwestern Medical Center 49
Not applicableLooking for participantsNCT05469373
What this trial is testing

ESIS in Pediatric DRE

Who this might be right for
Epilepsy
Sarah Katie Ihnen 86
Not applicableLooking for participantsNCT07571304
What this trial is testing

Dual-Task Training in Pediatric Multiple Sclerosis

Who this might be right for
Pediatric-Onset Multiple Sclerosis (POMS)
Istanbul University - Cerrahpasa 22
Testing effectiveness (Phase 2)Study completedNCT03650452
What this trial is testing

A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of TAK-935 (OV935) as an Adjunctive Therapy in Pediatric Participants With Developmental and/or Epileptic Encephalopathies

Who this might be right for
EpilepsyDravet SyndromeLennox-Gastaut Syndrome
Takeda 141
Not applicableStudy completedNCT01396343
What this trial is testing

Environmental and Genetic Risk Factors for Pediatric Multiple Sclerosis

Who this might be right for
Pediatric Multiple Sclerosis
University of California, San Francisco 1,276
Early research (Phase 1)UnknownNCT02200718
What this trial is testing

NeuroVax™, a Novel Therapeutic TCR Peptide Vaccine for Pediatric Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Immune Response BioPharma, Inc. 12
Large-scale testing (Phase 3)WithdrawnNCT02428218
What this trial is testing

Placebo-Controlled Study of the Efficacy and Safety of BG00012 in Pediatric Subjects With Relapsing-Remitting Multiple Sclerosis (RRMS)

Who this might be right for
Relapsing-Remitting Multiple SclerosisRelapsing Forms of Multiple Sclerosis
Biogen
Large-scale testing (Phase 3)Active Not RecruitingNCT03958877
What this trial is testing

Evaluate the Safety, Tolerability, and Efficacy of BIIB017 (Peginterferon Beta-1a) in Pediatric Participants for the Treatment of Relapsing-Remitting Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Biogen 152
Not applicableStudy completedNCT04441229
What this trial is testing

Mobile Attentional Bias Modification Training in Pediatric MS

Who this might be right for
Pediatric Multiple Sclerosis
NYU Langone Health 37
Not applicableNot Yet RecruitingNCT06870968
What this trial is testing

FIT-ATOMIC Exercise Feasibility Trial

Who this might be right for
Neuroinflammatory DiseasesMultiple Sclerosis
The Hospital for Sick Children 40
Large-scale testing (Phase 3)Active Not RecruitingNCT04926818
What this trial is testing

Efficacy and Safety of Ofatumumab and Siponimod Compared to Fingolimod in Pediatric Patients With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis (MS)
Novartis Pharmaceuticals 129
Next Page